2015
DOI: 10.4067/s0034-98872015001000004
|View full text |Cite
|
Sign up to set email alerts
|

Variantes de hemoglobina en una población con impresión diagnóstica positiva para hemoglobinopatías en Colombia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
3
0
3

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 10 publications
(7 reference statements)
0
3
0
3
Order By: Relevance
“…In Colombia, there are some studies with previous reports, one of them reported by Romero-Sánchez and collaborators, 10 which was conducted from 2009 to 2012 with patients from different cities of the country (whose data we included in this study), with a different geographical distribution; a frequency of hemoglobinopathies of 34.5% was described, the sickle cell trait and sickle cell anemia being the most important. In another study conducted in Cali, Colombia, in a retrospective cohort of 152 patients in whom capillary electrophoresis was performed, 42.7% presented some type of hemoglobinopathy, with the sickle cell trait (Hb AS) in 14.5%, followed by sickle cell disease (Hb SS) in 11.8%, being the most prevalent, but with a smaller sample size than ours.…”
Section: Discussionmentioning
confidence: 92%
“…In Colombia, there are some studies with previous reports, one of them reported by Romero-Sánchez and collaborators, 10 which was conducted from 2009 to 2012 with patients from different cities of the country (whose data we included in this study), with a different geographical distribution; a frequency of hemoglobinopathies of 34.5% was described, the sickle cell trait and sickle cell anemia being the most important. In another study conducted in Cali, Colombia, in a retrospective cohort of 152 patients in whom capillary electrophoresis was performed, 42.7% presented some type of hemoglobinopathy, with the sickle cell trait (Hb AS) in 14.5%, followed by sickle cell disease (Hb SS) in 11.8%, being the most prevalent, but with a smaller sample size than ours.…”
Section: Discussionmentioning
confidence: 92%
“…Se observó un patrón similar en el boletín epidemiológico del mismo año para la enfermedad de células falciformes, donde la edad media de diagnóstico fue de 9 años 7 . La hemoglobinopatía más frecuente fue el rasgo de células falciformes (Hb S) con 14,5%, seguido de la enfermedad de células falciformes (Hb SS) con 11,8%, que fue similar a estudios nacionales e internacionales previos 1,2,6,10,11 . Es importante mencionar que los resultados de CE reportados en este estudio fueron calculados para niños en riesgo siendo estudiados por anemia, y no con fines de tamizaje, por lo tanto, la prevalencia pue- de ser mayor en comparación con otros hospitales en Colombia.…”
Section: Discussionunclassified
“…En contraste, la detección en recién nacidos favorece la supervivencia y una mejor calidad de vida para los pacientes pediátricos 5 . Por lo tanto, esperamos que este estudio genere conciencia entre los profesionales de la salud para sospechar estos trastornos en pacientes pediátricos con anemia y promover el diagnóstico temprano en el entorno de atención primaria, o mejor aun desde el punto de vista de tamizaje, evitando complicaciones futuras como se mencionó anteriormente 7,11,20 .…”
Section: Discussionunclassified
“…In Colombia, haemoglobinopathies and erythrocyte defects prevail, with frequencies ranging from 2.4 to 70% being reported in different regions of the country. The results of population studies of some of these resistance variants have also been reported [16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33], but thus far, no study has been carried out that establishes, in a population endemic to malaria, such as Buenaventura, the prevalence of all previously mentioned resistance variants, the genotypic combinations that are found and in which proportion and which population distribution variables (such as sex, age and community) in uence the genotypes of these resistance variants.…”
Section: Introductionmentioning
confidence: 91%